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The authors consider acute problems in the quality and
management of medical services challenging health care
systems worldwide. This actuality has motivated the repre-
sentatives of the European Association of Predictive,
Preventive and Personalised Medicine and European
Federation of Clinical Chemistry and Laboratory Medicine
to consider the efforts in promoting an integrative
approach based on multidisciplinary expertise to advance
health care. The position paper of EPMA and EFLM [1]
provides a global overview of the problems related to med-
ical services: pandemic scenario in the progression of com-
mon chronic diseases, delayed interventional approaches
of reactive medicine, poor economy of health care systems,
lack of specialised educational programmes, problematic
ethical aspects of treatments as well as inadequate com-
munication among professional groups and policy makers.
The common position is focused on the patients’ needs,
expert recommendations for the relevant medical fields
and plausible solutions which have a potential to advance
health care services if the long-term strategies were to be
effectively implemented as proposed in the position paper.
In particular, the paper makes following statements:
➣ Since chronic pathologies are generally triggered at
the molecular level with consequent symptomatic manifes-
tation of the disease, a laboratory based detection of
pathology-specific molecular patterns would create a well-
founded basis for the desirable predictive medical services
giving the opportunity for optimal health care. This
requires the application of innovative biotechnologies to
predict human pathologies, the devising of appropriate
and timely preventive strategies and individualised treat-
ment planning.
➣ Multimodal diagnostics represents a model-based
examination procedure with several levels of examination
resulting in extended patient profiles and medical records
which obligate inclusion of an interview with the patient/
a questionnaire filled in for relevant information on any
known pathology, medical imaging, laboratory diagnostics
and evaluation of relevant risk factors. For laboratory diag-
nostics, it is highly recommended to use minimally inva-
sive validated blood tests for the detection of stage-specific
molecular patterns at complementary levels of targeted
regulation (DNA polymorphisms, transcripts, protein
expression, posttranslational modification, stage-specific
sub-cellular imaging, shifted enzymatic activity etc.).
➣ Shifting the role of laboratory from the ‘passive per-
forming’ to the ‘active advising’ is the next paradigm
change in health care. This reconsideration of the labora-
tory-clinician interface might significantly advance the
quality of current medical services, although the imple-
mentation of this approach across countries should be
adapted to local conditions.
➣ The globalisation of markets and laboratory related
business requires the comparability, or the unification, of
laboratory test values. The mobility of both patients and
health care professionals as well as the increasing global
data flow require such comparability. Hence, the unifica-
tion of laboratory tests should be placed at the top of the
list of corresponding adapting measures.
➣ A new generation of ‘point-of-care’ monitoring
devices is required. These mobile health technologies
must enable both the remote management of the analyti-
cal process and the active engagement of laboratory pro-
fessionals at the clinical level.
➣ Regarding the promotion of the concepts of ‘partici-
patory’ medicine, people need to be advised of reliable
information sources that are well adapted to a correspond-
ing level of understanding (categories of children, youth
and adults) and concrete interests of subpopulations (level
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of education, groups of professionals, patient cohorts). In
the field of education, laboratory medicine may play a
leading role providing up-to-date information that is
accessible to the layman on laboratory tests and their
interpretation for individual health and disease conditions.
A professional version will enable for a detailed knowledge
about bioactive molecules, enzymatic reactions, molecular
and cellular processes which underlie the pathomechan-
isms of individual predispositions and pathologies as well
as medical treatments.
➣ A creation of innovative medical records should be
considered as a priority for scientific programmes of mul-
tidisciplinary character. An integrative bioinformatics is
considered as the powerful tool to fulfil this highly ambi-
tious task.
➣ Progressing from ‘disease care’ to ‘health care’ means
a mandated implementation of a new philosophy of the
well-being concept tailored to the person (age, gender,
socio-economic status, individual predispositions, patient-
specific profile etc.) as a carefully elaborated spectrum of
measures for professional care that promotes the mental
and physical health of an individual concept.
➣ Considering the sensitive ethical aspects of the
laboratory medicine and biobanking, robust information
governance of the database and high quality of ethical
standards are the prerequisites for the successful imple-
mentation of PPPM in health care systems.
➣ Currently, bio-banking is facing major viability
challenges. These critical problems may be optimally
solved by relevant professional groups with complemen-
tary expertise such as the International Federations of
Laboratory Medicine, EPMA and ESBB followed by ade-
quate decisions of policymakers resulting in the creation
of a robust juristic platform.
➣ Standardisation of health care services in Europe is
a strategic issue for policymakers after detailed consulta-
tions with health care professionals.
➣ Professional education: we need to develop a new
culture among experts in order to promote the multidis-
ciplinary character of predictive, preventive and persona-
lised medicine and concomitantly to advance currently
deficient health care services. The innovative PPPM-
related educational programmes for professionals should
be prioritised in the Common Strategic Framework (also
called as the New European Framework Programme Hor-
izon 2020) as well as by other global and topic-relevant
national programmes.
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